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Introduction
In the recent years fluorescence-guided surgery gained interest among the scientific community and related publications are growing. [1] [2] [3] [4] [5] [6] Different medical and surgical specialties (dermatology, pulmonology, urology, neurosurgery, gastro-intestinal surgery and plastic and reconstructive surgery) are currently using fluorescence imaging techniques for angyographic purpose, as well as for cancer/premalignant lesions detection, and/or lymph nodes mapping. [1] [2] [3] [4] [5] [6] These fluorescence imaging techniques are based on the administration of indocyanine green (ICG), a soluble dye which emits a fluorescent light when illuminated by an infrared laser source. 7 ICG has also been used in the last decades to evaluate hepatic function before liver surgery. 8 The application of the fluorescent properties of ICG for liver neoplasms identification and characterization was also recently investigated. The first application of this imaging technique in hepatic surgery was reported by Ishizawa et al. in 2009. 9 Up to date, with special reference to this possible application, clear rules for how to manage ICG (dose, time and site of administration) are lacking.
Aim of this systematic review is to collect data from current publications on the possible oncological value of indocyanine green in liver surgery for malignant diseases, and to clarify the management of ICG. Publications were considered from the beginning of 2008 to the end of 2016. Keywords for search item were: liver tumor, indocyanine green, photodynamic eye, navigation in surgery, hepatectomy. MeSH terms were: indocyanine green/liver surgery, idocyanine green/navigation, indocyanine green/cholangiography. Preference has been given to English publications. All references in selected articles were further screened for additional publications. Articles were retrieved according to the Preferred Items for Reporting of Systematic Reviews and Meta-Analyses guidelines (Figure 1 ).
Study selection
Articles were selected if their abstract showed a clinical usefulness of application of indocyanine green in hepatic surgery. Papers reporting use of indocyanine green in other surgical areas, as well as the preoperative setting for hepatic function evaluation, or explaining characteristics of indocyanine green itself, were excluded.
Data extraction
For all eligible studies, a standard Excel data form was filled in and the following data were extracted: study design, number of cases, management of indocyanine green (dose, time and method of administration), type of surgery, outcome variables, false positive and accuracy value, if reported. For statistical analysis, P<0.05 was considered significant, when available.
Methodological quality assessment
Two reviewers (SM and GLB) independently assessed the study quality according to the Newcastle-Ottawa scale, including the selection of patients, the reproducibility of the procedure, comparability of groups, and ascertainment of outcome of interest (being most of the analyzed studies a monocentric single series, without control group). The high-quality study was defined as a study with ≥6 awarded stars.
Results
Titles and abstracts of a total of 1331 articles were screened separately by 2 authors for eligibility.
Among those, 1296 were excluded, either for having abstract unavailable (n=25), or for describing other possible application of indocyanine green (i.e. for hepatic function or for not-hepatic surgery (n=750), or being irrelevant to our topic (n=371).Congress presentation and letters to the editor (150) were excluded from the analysis. Of the remaning 35 articles, 16 of which were excluded after full text examination, either for being narrative review (n=4, these have been cited in Discussion section [29, 31, 32, 33] ), or being irrelevant as comments to other papers (n=7), or only available in abstract form (n=5).
The remaining 19 articles were fully analyzed and data were extracted as summarized in Tables 1-4 . [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] A total of 718 cases were globally analyzed as study group. No side effects of ICG were reported in any articles.
The majority of studies are prospective observational (n=12) and one only randomized prospective study was found. Two casecontrol study, three case reports and one experimental on animal model study were also included. Considering similar outcome variables, as defined in each articles, it appears reasonable to identify three different fields of application of indocyanine green in hepatic surgery: detection of surface lesions, segmental staining, biliary anatomy investigation (for biliary leakage detection and for staining of biliary tree, the so-called fluorescence cholangiography).
Detection and characterization of surface liver lesions
Articles and data regarding this topic and relative managing of indocyanine green are summarized in Table 2 .
464 patients were included in these studies; dose, site and time of injection of ICG were reported in each article. The dose ranged from 0.25 mg/kg to 2.5 mg/kg; the site of injection of ICG was always intravenous; time of iv injection ranged from one to fourteen days before surgery. Accuracy and false positive value, when reported, range from 50% to 100% and from 0% to 50% respectively. If published, P value was <0.05 comparing ICG to intra-operative ultra-sound in detection of other lesions, unknown before surgery (missed lesions), in favor of ICG fluorescence.
Review
All the articles agree in recognizing that this technique is of limited value in detection of deep nodules (>10 mm from the surface) and has a high rate of false positive results in cirrhotic liver.
Segmental staining
Articles and data regarding this topic and relative managing of ICG are summarized in Table 3 . A total of 64 patients were included in the analysis. ICG dose ranges from 0.25 mg/kg to 2.5 mg/kg while site of injection was always intra-portal branch of liver segment involved in hepatic resection and time was always intra-operative. All the 3 articles showed a 100% accuracy in segmental staining.
[ 4 The control group underwent a leak test after hepatic resection with ICG dye alone. 5 The experimental group underwent a leak test with ICG dye, followed by ICG fluorescent cholangiography using the Photodynamic Eye. NR, not reported; NS, not significant; HCC, hepatocellular carcinoma; IOUS, intra-operative ultra-sound. 
Evidence of biliary tree and/or bile leakage during hepatectomy
Articles and data regarding this topic and relative managing of ICG are summarized in Table 4. 192 patients were analized with ICG dose that ranges from 0.025 mg/kg to 2.5 mg/kg. Site of injection was either intravenous or intra-biliary (most frequently, the cystic duct was cannulated). Time of injection ranges from intra-operative to 2-4 days before surgery. Each article publishes an accuracy of 100% in detection biliary tree during liver resection. One randomized prospective study 19 demonstrates a statistically significant difference (P<0.05) in post-operative biliary leakage comparing control group (patients underwent a leak test after hepatic resection with ICG dye alone injected via biliary duct) to experimental group (patients underwent a leak test with ICG dye, followed by ICG fluorescent cholangiography using the Photodynamic Eye).
Discussion
Interest to ICG-guided surgery is growing in the liver surgery community. ICG is already used by surgeons since many years to put indications for liver resection as described by Makuuchi et al. 28 The test is generally performed three days before surgery on average (1 to 7 days for HCC and 1 to 14 days for metastases). 9 Trading on the administration of ICG to test the liver function, many teams described the potentially intraoperative usefulness of this technique for surgical and for oncological purposes.
During the intervention, the investigation is performed by placing the infrared camera above the liver. The light in the operation room should be decreased as much as possible to improve the contrast of images seen on the screen. In some cases, ICG may be retained by cancer cells, due to reduced biliary delivery; however, more frequently, the same happens in a parenchymal ring surrounding the tumor, which is compressed and do not work as the normal tissue. The contrast between fluorescent and non-fluorescent areas closely depends on the interval between the time of ICG injection and the timing of fluorescence measurement, as well as on the liver function. On the other side, visualization of liver segmentation is closely related to the ability of selectively inject ICG in portal branches, usually under US guidance. Finally, the presence of fluorescence in bile structures depends upon the hepatic metabolism, thus it is related to the timing of iv injection. The exact optimal dosage and timing still remains to be defined. 7, 29 Technical aspects and historical context of ICG fluorescence are well reported in the review by Reinhart et al., 30 but pathophysiological mechanisms of ICG secretion are not totally elucidated. 31 Possible uses in oncological surgery are summarized in two reviews. 32, 33 Many articles has been published about the staining of biliary tree during cholecystectomy as described by Boni et al. 34 but it was not the goal of our review.
Review

Detection and characterization of surface liver lesions
Clearly, the most important limitation of this technique in detecting tumoral nodules is the lack of evidence of deep lesions. 7, 29 On the other side, many advantages are described in detection of small nodules unknown before surgery with a statistical significant difference compared to intra-operative ultrasound. 9, 13, 19, 21 Ishizawa et al. 9 showed in their report that 13% of lesions were not evident unless observed by ICG fluorescent imaging. Gotoh et al. 13 found 40% of new HCC nodules that were not detected by any preoperative and intraoperative examination, including IOUS.
Furthermore, ICG could be useful in tumor characterization: several Authors describe different grade of staining of fluorescent view related to type of lesion (HCC vs metastases vs cholangiocarcinoma) 9, 10, 22, 25 or to grade of differentiation. 13 Ishizawa et al. 9 defined, as a pattern of staining, that well-differentiated HCCs appeared as uniformly fluorescing lesions with higher lesion-toliver contrast than that of moderately or poorly differentiated HCCs (P<0.001), while metastases were delineated as rim-fluorescing lesions. However, there are not at the moment sufficient data to address this issue. Other fields of interest would be the final check of a free margin, as mentioned by Zhang et al., 27 and the detection of extra-hepatic (i.e. hepatic pedicle nodes) metastases, as described by Takahashi et al. 24 With reference to the management of ICG administration, the majority of the Authors used a standard dose of 0.5 mg/kg injected during the pre-operative test aimed at liver function evaluation, as described in Table 2 . The only published case-control study 25 suggests injecting 10 mg of ICG intravenously the day before surgery, which guarantees a high accuracy rate. Thus, this dose may be suggested as a standard dose for hepatic lesions detections; further confirmation studies are needed, with special reference to the relationship with hepatic function.
Segmental staining
Since Torzilli & Makuuchi 35 described intraoperative ultrasonography during liver resection, this technique is the goal standard to guide hepatic surgeons. A possible easy alternative way to perform segmental resection has been described by some Authors, as shown in Table 3 10,11,17 based on segmental fluorescent staining with ICG, injected during the intervention in the intrahepatic portal branches, with a dose ranging from 0.25 mg/kg to 5 mg/kg. However, only small series and anecdotal data are available by now to confirm the usefulness of this technique.
Evidence of biliary tree and/or bile leakage during hepatectomy
A full agreement seems to be evident in the Literature, either in managing of ICG and in possible fields of application for biliary anatomy and biliary leakage detection during surgery, as demonstrated in Table 4 . The accuracy of biliary tree staining is 100% in all the reported series, either during cholecystectomy 15, 16, 34 and during hepatic resection (for example to detect left or right hepatic ducts involved by neoplasm 14, 16, 20 ) . ICG search may prove useful for intraoperative bile leakage detection after liver resection; the only available prospective randomized study shows a statistically significant advantage in the ICG fluorescent staining arm. 18 The dosage proposed to this intent ranged from 0.025 mg/kg to 0.25 mg/kg when direct injection of ICG in bile duct is provided, and 2.5 mg/kg when intravenous injection is performed, some variable time before the surgical intervention or following intubation as shown in Table 4 .
Two recent studies of our Institution have shown the optimal dosage and timing of administration of ICG to give a good visualization of hepatic lesion. 36, 37 
Conclusions
In conclusion, our review suggests different fields of application of ICG fluorescence detection in hepatic surgery and, with limitations due to relative few data available, different ways to manage of ICG to different purposes are reported. Future studies about relationship between managing of ICG and liver function are needed.
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